Fig. 2
From: Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
Hazard ratio (HR) and 95% confidence intervals (CI) according to different values of basal CD73 enzyme activity
Fig. 2 | Journal of Translational Medicine